Bacterial Crosstalk via Antimicrobial Peptides on the Human Skin: Therapeutics from a Sustainable Perspective
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, S.M. | - |
dc.contributor.author | Keum, H.L. | - |
dc.contributor.author | Sul, W.J. | - |
dc.date.accessioned | 2023-10-04T03:40:29Z | - |
dc.date.available | 2023-10-04T03:40:29Z | - |
dc.date.issued | 2023-01 | - |
dc.identifier.issn | 1225-8873 | - |
dc.identifier.issn | 1976-3794 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/67951 | - |
dc.description.abstract | The skin’s epidermis is an essential barrier as the first guard against invading pathogens, and physical protector from external injury. The skin microbiome, which consists of numerous bacteria, fungi, viruses, and archaea on the epidermis, play a key role in skin homeostasis. Antibiotics are a fast-acting and effective treatment method, however, antibiotic use is a nuisance that can disrupt skin homeostasis by eradicating beneficial bacteria along with the intended pathogens and cause antibiotic-resistant bacteria spread. Increased numbers of antimicrobial peptides (AMPs) derived from humans and bacteria have been reported, and their roles have been well defined. Recently, modulation of the skin microbiome with AMPs rather than artificially synthesized antibiotics has attracted the attention of researchers as many antibiotic-resistant strains make treatment mediation difficult in the context of ecological problems. Herein, we discuss the overall insights into the skin microbiome, including its regulation by different AMPs, as well as their composition and role in health and disease. © 2023, The Author(s), under exclusive licence to Microbiological Society of Korea. | - |
dc.format.extent | 11 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | The Korean Society for Mocrobiology / The Korean Society of Virology | - |
dc.title | Bacterial Crosstalk via Antimicrobial Peptides on the Human Skin: Therapeutics from a Sustainable Perspective | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/s12275-022-00002-8 | - |
dc.identifier.bibliographicCitation | Journal of Microbiology, v.61, no.1, pp 1 - 11 | - |
dc.identifier.kciid | ART002929900 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000922510000001 | - |
dc.identifier.scopusid | 2-s2.0-85147108400 | - |
dc.citation.endPage | 11 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.title | Journal of Microbiology | - |
dc.citation.volume | 61 | - |
dc.type.docType | Review; Early Access | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Antimicrobial peptides | - |
dc.subject.keywordAuthor | Bacterial-bacterial interaction | - |
dc.subject.keywordAuthor | Bacteriotherapy | - |
dc.subject.keywordAuthor | Host-bacterial interaction | - |
dc.subject.keywordAuthor | Skin microbiome | - |
dc.subject.keywordPlus | PHENOL-SOLUBLE MODULINS | - |
dc.subject.keywordPlus | QUORUM-SENSING SYSTEM | - |
dc.subject.keywordPlus | STAPHYLOCOCCUS-AUREUS | - |
dc.subject.keywordPlus | VIRULENCE | - |
dc.subject.keywordPlus | EPIDERMIDIS | - |
dc.subject.keywordPlus | MICROBIOTA | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | DETERMINANTS | - |
dc.subject.keywordPlus | LANTIBIOTICS | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.